Citadel Advisors - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAD3. A total of 11 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$12,225,021
-61.5%
11,901,000
-57.3%
0.00%
-57.1%
Q1 2023$31,737,623
-57.4%
27,901,000
-63.2%
0.01%
-58.8%
Q4 2022$74,474,061
-16.4%
75,901,000
-0.8%
0.02%
-15.0%
Q3 2022$89,082,000
-2.0%
76,490,000
-11.6%
0.02%
-13.0%
Q2 2022$90,901,00086,490,0000.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 45,200,000$51,456,1323.35%
CSS LLC/IL 17,945,000$20,505,4821.35%
READYSTATE ASSET MANAGEMENT LP 12,000,000$13,644,0001.27%
Boussard & Gavaudan Investment Management LLP 8,527$9,707,4530.91%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 32,000,000$36,310,7200.81%
LINDEN ADVISORS LP 35,247,000$40,079,8040.42%
WHITEBOX ADVISORS LLC 1,000,000$1,132,0000.04%
FRANKLIN RESOURCES INC 63,000,000$71,631,0000.04%
D. E. Shaw & Co., Inc. 22,500,000$25,622,5750.03%
KORNITZER CAPITAL MANAGEMENT INC /KS 600,000$679,2000.01%
View complete list of PTC THERAPEUTICS INC shareholders